Abstract # 2141 A Phase II Study of Imatinib Mesylate In Prostate Cancer Patients With Evidence of Biochemical Relapse Following Definitive Radical Retropubic Prostatectomy or Radiation Therapy

Presenter: Bajaj, Gopal

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results

> Conclusions

> View tables/images/videos


Authors:
Bajaj, Gopal Krishna (1) ; Garret-Mayer, Elizabeth (3) ; Zhang, Zhe (3) ; Drew, Renee (1) ; Sinibaldi, Vickie (2) ; Gaver, Matt (1) ; Pili, Roberto (2) ; Denmeade, Samuel R. (2) ; Carducci, Michael A. (2, 4) ; Nelson, William G. (2, 4) ; Eisenberger, Mario A. (2, 4) ; DeWeese, Theodore L. (1, 4) .


Institutions:
1. Department of Radiation Oncology and Molecular Radiation Sciences, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
2.
Department of Medical Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.

3.
Department of Biostatistics, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.

4.
James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA.



E-mail a friend about this abstract:
Enter email address:   





Abstracts main page


Logout